Enhancement of TRAIL/Apo2L-mediated apop
✍
Xiu-Xian Wu; Yoshiyuki Kakehi; Youichi Mizutani; Hiroyuki Nishiyama; Toshiyuki K
📂
Article
📅
2003
🏛
John Wiley and Sons
🌐
French
⚖ 639 KB
## Abstract Renal cell carcinoma (RCC) is one of the most drug‐resistant malignancies in humans. We show that adriamycin (ADR) and TNF‐related apoptosis‐inducing ligand (TRAIL)/Apo2L have a synergistic cytotoxic effect against RCC cells. This synergistic cytotoxicity was obtained in ACHN, A704, Cak